The site, which covers an area of 300,000 square metres, is located in the township of Nerviano, 30km from Milan, and employs around 340 permanent staff. Separately, Actavis has entered into a multi-year exclusive agreement with Pfizer for the supply of oncology products.
Actavis plans to develop new products and transfer existing products into Nerviano over the coming years and the site will work very closely with Actavis’s Bucharest operation which also develops and manufactures oncology products. The transaction is expected to be completed by the end of January 2008.
Robert Wessman, CEO and president of Actavis, said: “This transaction will enable us to meet the exciting growth projections we see for our oncology product portfolio over the coming years.”